Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Call: Horizon Pharma PLC NOV 21 EXP 11/16/18

CUSIP: G4617B44K | 1 institutional holders

Quarters

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile